Testing for COVID-19 in lung cancer patients
Open Access
- 9 April 2020
- journal article
- editorial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 31 (7), 832-834
- https://doi.org/10.1016/j.annonc.2020.04.002
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of Health
This publication has 17 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- COVID-19 and smoking: A systematic review of the evidenceTobacco Induced Diseases, 2020
- Sex difference and smoking predisposition in patients with COVID-19The Lancet Respiratory Medicine, 2020
- Coronaviruses: Facts, Myths, and HypothesesJournal of Thoracic Oncology, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic ReviewInternational Journal of Environmental Research and Public Health, 2018
- Inflammatory Diseases of the Lung Induced by Conventional Cigarette SmokeChest, 2015